Shionogi & Co., Ltd. (TYO:4507)
2,257.50
+59.50 (2.71%)
Feb 21, 2025, 3:30 PM JST
Shionogi & Revenue
Shionogi & had revenue of 119.63B JPY in the quarter ending December 31, 2024, with 12.56% growth. This brings the company's revenue in the last twelve months to 456.87B, up 7.46% year-over-year. In the fiscal year ending March 31, 2024, Shionogi & had annual revenue of 435.08B with 1.97% growth.
Revenue (ttm)
456.87B
Revenue Growth
+7.46%
P/S Ratio
4.21
Revenue / Employee
92.13M
Employees
4,959
Market Cap
1,920.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 435.08B | 8.40B | 1.97% |
Mar 31, 2023 | 426.68B | 91.55B | 27.32% |
Mar 31, 2022 | 335.14B | 37.96B | 12.77% |
Mar 31, 2021 | 297.18B | -36.19B | -10.86% |
Mar 31, 2020 | 333.37B | -30.35B | -8.34% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |
Shionogi & News
- 18 days ago - Shionogi and Jordan's Guardian Angels Announce First-Ever Human Drug Study for Jordan's Syndrome, an Ultra-Rare Genetic Neurodevelopmental Disorder - Benzinga
- 21 days ago - Shionogi & Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 21 days ago - Shionogi targets JPY550B revenue through QOL focus and global expansion - Seeking Alpha
- 21 days ago - Shionogi & Co., Ltd. (SGIOY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Shionogi & Co. reports 9M results - Seeking Alpha
- 4 months ago - Shionogi & Co., Ltd. (SGIOY) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Antibiotics, an important but tricky business, says Shionogi CEO [Advocacy Lab Content] - EURACTIV.com
- 7 months ago - Shionogi & Co., Ltd. (SGIOY) Q1 2024 Earnings Call Transcript - Seeking Alpha